With U.S. Leadership, Global Fund Raises $14 Billion, Largest Amount Ever Pledged to an International Health Organization

With U.S. Leadership, Global Fund Raises $14 Billion,
Largest Amount Ever Pledged to an International Health Organization

Major donors step forward with significantly increased pledges for Sixth Replenishment

Lyon, France – Today the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) raised $14.02 billion, the largest amount of money ever raised for an international health organization.

During the Global Fund’s Sixth Replenishment conference, hosted by French President Emmanuel Macron, donor countries significantly increased their contributions to fight the world’s deadliest infectious diseases.

Canada, the European Union, France, Germany, Ireland, Italy, Portugal and the United Kingdom all increased their pledges by at least 15 percent. The Global Fund also received unprecedented funding from implementing countries and the private sector, with a 50 percent increased pledge from (RED).

“Major donors, including the United States Congress, affirmed their support for the Global Fund’s results-oriented, lifesaving work,” said Chris Collins, President of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria (Friends). “It’s a huge victory for global health and for international collaboration to tackle global challenges.”

Both the House of Representatives and the Senate Appropriations Committee have approved a 15.6 percent increase in annual funding to the Global Fund, $1.56 billion for fiscal year 2020. House and Senate bills refer to this funding as a “first installment” for the three-year Sixth Replenishment cycle.  Senate report language anticipates continuing this level of funding through the Replenishment cycle, which would mean a total of $4.68 billion for the Sixth Replenishment. Congress has not yet finalized fiscal year 2020 appropriations legislation.

“The United States works hand-in-hand with the Global Fund to deliver efficient and effective programs that save lives, strengthen economic growth and reinforce global health security,” said Representative Pete Aguilar. “We believe these programs exemplify the generosity of the American people we represent. We share the belief that nobody should die from a preventable disease.”

If the $1.56 billion funding level is enacted for fiscal year 2020, this would be the first U.S. funding increase to the Global Fund in six years and the third largest increase in U.S. funding since the founding of the Global Fund.

“Thank you to the U.S. Congress for your leadership and commitment to the Global Fund,” said Friends Board Chair Dr. Jeffrey L. Sturchio. “You have signaled to the rest of the world that America remains dedicated to ending the deadly epidemics of AIDS, tuberculosis and malaria, and have encouraged other countries to step up their investments too.”

By reaching the ambitious $14 billion investment goal, the Global Fund will be able to lead an international effort to get back on track to ending the AIDS, TB and malaria epidemics and save an estimated 14,600 lives a day over the next three years.


ABOUT FRIENDS OF THE GLOBAL FIGHT AGAINST AIDS, TUBERCULOSIS AND MALARIA: Friends of the Global Fight Against AIDS, Tuberculosis and Malaria advocates for U.S. support of the Global Fund, and the goal to end the epidemics of AIDS, tuberculosis and malaria. For more information about Friends of the Global Fight, visit www.theglobalfight.org.

ABOUT THE GLOBAL FUND: The Global Fund is a partnership designed to accelerate the end of AIDS, tuberculosis and malaria as epidemics. As an international organization, the Global Fund mobilizes and invests more than US$4 billion a year to support programs run by local experts in more than 100 countries. In partnership with governments, civil society, technical agencies, the private sector, faith-based organizations and people affected by the diseases, we are challenging barriers and embracing innovation. Learn more at https://www.theglobalfund.org/en/overview.


Samantha Majerus, [email protected]